Pharma News

The FDA has granted a Priority Review designation to AstraZeneca’s Biologics License Application (BLA) for tremelimumab as adjunct therapy to the company’s blockbuster drug Imfinzi (durvalumab...

Seven companies have been named in advertisements for bringing discredit upon, and reducing confidence in, the pharmaceutical industry. In addition, Janssen was publicly reprimanded.

Astellas Pharma said it will end three gene therapy programs for the treatment of patients with Duchenne muscular dystrophy (DMD) based on disappointing preclinical data, along with several other p...

A combination of high-dose Vitamin D, Omega-3s, and simple home strength exercises can help reduce cancer risk in healthy adults aged 70 or older by 61 per cent, claims a study. ...

Days after throwing down $350 million to beef up biologics manufacturing in Indiana, high-flying CDMO Catalent is buying a cell therapy plant on the East Coast. ...

The FDA granted fast track designation to CMG901 for treatment of certain patients with gastrointestinal cancers.

A massive study has analyzed the genomes of cancer cells from more than 12,000 patients, identifying 58 new mutational signatures that offer clues to novel causes of cancer.  ...

Almost three-quarters of antibiotic prescriptions to patients aged 65 years or older and two-thirds to Black patients are inappropriate, according to a U.S. study of more than 7 billion visits to d...

San Diego, Calif.-based Arcturus Therapeutics said that its messenger RNA (mRNA) vaccine has demonstrated strong protection against COVID-19 in a large late-stage study. ...

Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people's health and the quality of patients' lives, today announced that the U.S. Food and Drug Admini...

Axsome Therapeutics is likely on the cusp of its first drug approval, sending shares of its stock up more than 40% pre-market on Tuesday.

Enzyvant, which focuses on developing regenerative medicines for rare diseases, has laid out plans to build a new manufacturing facility in the Research Triangle Park area of North Carolina. ...